ArticleOncotarget2014

HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound.

Alberto Ramírez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.